Evaluation of drug-induced photosensitivity by UVB photopatch testing

Contact Dermatitis

Volumn 39, Issue 4, 1998, Pages 200-

  Schwarze, H P ^a   Albes, B ^a   Marguery, M C ^a   Loche, F ^a   Bazex, J ^a  

^a CHU PURPAN   (France)

Author keywords

Adverse drug reactions; Althiazide; Photopatch testing; Photosensitivity; Thiazide diuretics; UVA and UVB radiation

Indexed keywords

ALDACTAZINE; ALTIZIDE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERTENSION; IRRADIATION; PHOTOALLERGY; PHOTOPATCH TEST; ULTRAVIOLET B RADIATION;

AGED; BENZOTHIADIAZINES; DIURETICS; DRUG COMBINATIONS; DRUG ERUPTIONS; FEMALE; HUMANS; PATCH TESTS; PHOTOSENSITIVITY DISORDERS; SKIN; SODIUM CHLORIDE SYMPORTER INHIBITORS; SPIRONOLACTONE; SULFONAMIDES; ULTRAVIOLET RAYS;

EID: 15644365786     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1998.tb05898.x     Document Type: Article

References (8)

1. Marguery M C. La réaction photoallergique: mecanisme d'apparition et technique d'exploration. Rev fr Allergol 1988: 38: 394-400.
2. Diffey B L. Phototoxic potential of thiazide diuretics in normal subjects. Arch Dermatol 1989: 125: 1355-1358.
3. Robinson H, Morison W, Hood A. Thiazide diuretic therapy and chronic photosensitivity. Arch Dermatol 1985: 121: 522-524.
4. Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996: 35: 871-887.
5. Gould J W, Mercurio M G, Elmets C A. Cutanous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995: 33: 551-573.
6. British Photodermatology Group. Workshop report: photopatch testing: methods and indications. Br J Dermatol 1997: 136: 371-376.
7. Youn J I, Lee H G, Yeo U C, Lee Y S. Piroxicam photosensitvity associated with vesicular hand dermatitis. Clin Exp Dermatol 1993: 18: 52-54.
8. Joseph-Charles J, Bertucat M. Dosage simultané de l'althiazide et de la spironolactone dans des comprimés par spectrophotométrie dérivée. STP Pharma Sciences 1993: 3: 254-259.